NCT05533788View on ClinicalTrials.gov

ABSK091 Food Effect Study in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 8, 2020

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions
Health, SubjectiveFood-drug Interaction
Interventions
DRUG

ABSK091 tablet

ABSK091 tablet which is being developed for the treatment of patients with advanced solid tumors

Trial Locations (1)

114202

Tri-Service General Hospital, Taipei

Sponsors
All Listed Sponsors
lead

Abbisko Therapeutics Co, Ltd

INDUSTRY